NEXGEL (NXGL) Director Sells 7,697 Shares at $2.36 Avg
NEXGEL director Henry Scott Robert sold 7,697 shares of the company's common stock on 09/25/2025 under a pre-established Rule 10b5-1 trading plan at a weighted average price of $2.3579 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
NEXGEL director Henry Scott Robert sold 7,697 shares of the company's common stock on 09/25/2025 under a pre-established Rule 10b5-1 trading plan at a weighted average price of $2.3579 per share. The shares were originally purchased on 03/01/2024. After the sale, the reporting person beneficially owns 121,356 shares, held directly. The filer notes the sale prices ranged from $2.3500 to $2.3900 and offers to provide a breakdown of shares sold at each price if requested.
Positive
- Sale executed under Rule 10b5-1 plan, providing procedural clarity about the timing of the transaction
- Reporting discloses original purchase date of the sold shares (03/01/2024), improving transparency
- Substantial remaining direct ownership of 121,356 shares indicates continued alignment with shareholders
Negative
- Insider disposed of 7,697 shares, representing a reduction in the director's stake
- Weighted-average sale price disclosure ( $2.3579 ) indicates sale occurred near recent trading levels, which may reflect limited premium
Insights
TL;DR: A director executed a small open-market sale under a 10b5-1 plan, leaving substantial direct ownership.
The transaction is routine insider liquidity executed via a Rule 10b5-1 plan, which reduces timing concerns about selective trading. The sale size (7,697 shares) should be evaluated relative to the director's remaining direct holding of 121,356 shares to assess ongoing alignment with shareholders. The weighted-average sale price of $2.3579 and disclosed price range provide clarity on execution.
TL;DR: The disclosure follows standard governance practice using a documented 10b5-1 plan and includes provenance of the sold shares.
The report appropriately discloses that the sold shares were purchased on 03/01/2024 and that the sale was executed under a 10b5-1 plan, which strengthens the procedural defensibility of the transaction. The reporting form indicates direct beneficial ownership after the sale, which is material to assessing director alignment with shareholders.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 7,697 | $2.3579 | $18K |
Footnotes (2)
- F1. The Reporting Person sold these shares pursuant to a Rule 10b5-1 trading plan. The shares were originally purchased by the Reporting Person in the open market on March 1, 2024.
- F2. Represents the weighted average of open market sale transactions ranging from $2.3500 to $2.3900 per share. The Reporting Person undertakes to provide full information regarding the number of shares sold at each separate price sold if requested by the Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did NEXGEL (NXGL) insider Henry Scott Robert do?
Was the sale part of an approved trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.